9:00 am – 4:00 pm – Park Inn by Radisson Hotel
Free of charge (Lunch will be provided).
flexiVent perturbations – Basics and applications
Frédéric Gagnon – emka TECHNOLOGIES
Extracellular vesicles: towards new therapeutic targets in idiopathic pulmonary fibrosis.
Dr. Olivier Burgy – INSERM U1231 – Université de Bourgogne, France
Inhalation of protein therapeutics : Opportunities and challenges
Dr. Rita Vanbever – Catholic University of Louvain, Belgium
Negative Pressure Forced expiration (NPFE) measurements in mouse models of lung disease
Dr. Jeroen Vanoirbeek – KU Leuven, Belgium
Alveolar micromechanics in TGF-ß1 overexpressing mice
Franziska Roeder, Hannover Medical School, Germany
expoCube: in vitro inhalation exposure at the airway-liquid interface
David Brunet – SCIREQ
PCLS models of bronchoconstriction: Details Matter!
David Brunet – SCIREQ
inExpose new features
Yasmine Ressaoui – emka TECHNOLOGIES
Rita Vanbever is Principal Investigator at the Louvain Drug Research Institute and Professor at the Faculty of Pharmacy and Biomedical Sciences of UCLouvain in Brussels, Belgium. Her research interests include the formulation of inhalation dry powders, the study of the pulmonary fate of actives, pulmonary vaccination and formulation strategies to sustain drug release within the lungs.
Olivier Burgy specialized in the field of pulmonary fibrosis, including cellular and molecular biology approaches based on in vivo and in vitro experimental models. He joined the Université Bourgogne Franche-Comté in 2019 and is now assistant professor of cell biology at the Health Science department of the University of Burgundy in Dijon. His lab at the U1231 Lipids, Nutrition, Cancer Research Center aims at deciphering the role of extracellular vesicles in chronic lung diseases. Dr Burgy is an active member of the European Respiratory Society and the American Thoracic Society and serves as reviewer of several scientific journals.
Franziska Roeder studied biochemistry at the Hannover Medical School and joined the Institute of Functional and Applied Anatomy for her Masterthesis. There she studied the postnatal development of surfactantproteins in rats. Being in contact with this topic, she got involved and very interested in lung research. In 2022, Franziska started her PhD in the working group of Prof. Lars Knudsen. Now she investigates the role of microatelectases in the development of ventilation-induced lung injury in the TGF-ß1 mouse model.
Jeroen Vanoirbeek is associate professor at the Faculty of Medicine at KU Leuven and affiliated with the research unit Environment & Health. His primary research focus is on inhalation and dermal exposure to noxious agents and adverse health effects in human cohorts and in experimental models. Lung functions assessment is an important asset in his research with small lab animals (mice, rat, rabbit pups).
